16 May 2017 Oryzon announces appointment of new Chief Medical Officer and expansion of its Medical Department
24 April 2017 ORYZON Announces New Grant from Alzheimer’s Drug Discovery Foundation (ADDF) to develop a companion marker for its ORY-2001 epigenetic drug
3 April 2017 ORYZON presents data on the Phase I trial with ORY-2001 at the 13th International Conference on Alzheimer’s and Parkinson’s diseases
20 March 2017 Oryzon to Present at the Sachs Associates 2nd Annual Neuroscience BioPartnering & Investment Forum
15 March 2017 ORYZON to Present at the 11th Annual BIO-Europe Spring International Partnering Conference
27 February 2017 ORYZON presented new preclinical data of ORY-2001 therapeutic activity in Multiple Sclerosis at ACTRIMS-2017